Bar Harbor Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-537
| Closed | -$202K | – | 239 |
|
|
2021
Q4 | $202K | Sell |
537
-31
| -5% | -$11.7K | 0.02% | 237 |
|
|
2021
Q3 | $234K | Sell |
568
-89
| -14% | -$36.7K | 0.02% | 219 |
|
|
2021
Q2 | $243K | Buy |
+657
| New | +$243K | 0.02% | 226 |
|
|
2020
Q4 | – | Sell |
-1,241
| Closed | -$281K | – | 241 |
|
|
2020
Q3 | $281K | Hold |
1,241
| – | – | 0.03% | 196 |
|
|
2020
Q2 | $216K | Buy |
+1,241
| New | +$216K | 0.03% | 216 |
|
|
2020
Q1 | – | Sell |
-2,367
| Closed | -$362K | – | 240 |
|
|
2019
Q4 | $362K | Sell |
2,367
-1,049
| -31% | -$160K | 0.04% | 225 |
|
|
2019
Q3 | $452K | Sell |
3,416
-9
| -0.3% | -$1.19K | 0.05% | 213 |
|
|
2019
Q2 | $486K | Buy |
3,425
+32
| +0.9% | +$4.54K | 0.06% | 205 |
|
|
2019
Q1 | $493K | Sell |
3,393
-46
| -1% | -$6.68K | 0.06% | 198 |
|
|
2018
Q4 | $389K | Sell |
3,439
-127
| -4% | -$14.4K | 0.05% | 208 |
|
|
2018
Q3 | $479K | Sell |
3,566
-116
| -3% | -$15.6K | 0.05% | 209 |
|
|
2018
Q2 | $414K | Sell |
3,682
-672
| -15% | -$75.6K | 0.05% | 213 |
|
|
2018
Q1 | $465K | Buy |
4,354
+386
| +10% | +$41.2K | 0.06% | 206 |
|
|
2017
Q4 | $434K | Buy |
3,968
+1,158
| +41% | +$127K | 0.05% | 207 |
|
|
2017
Q3 | $304K | Sell |
2,810
-558
| -17% | -$60.4K | 0.04% | 244 |
|
|
2017
Q2 | $341K | Buy |
3,368
+338
| +11% | +$34.2K | 0.04% | 234 |
|
|
2017
Q1 | $272K | Buy |
3,030
+134
| +5% | +$12K | 0.03% | 270 |
|
|
2016
Q4 | $221K | Hold |
2,896
| – | – | 0.02% | 333 |
|
|
2016
Q3 | $241K | Buy |
2,896
+178
| +7% | +$14.8K | 0.03% | 310 |
|
|
2016
Q2 | $224K | Buy |
+2,718
| New | +$224K | 0.03% | 292 |
|